Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 26
1991 67
1992 102
1993 104
1994 90
1995 133
1996 142
1997 150
1998 121
1999 126
2000 119
2001 128
2002 137
2003 124
2004 132
2005 146
2006 153
2007 151
2008 130
2009 132
2010 123
2011 135
2012 135
2013 126
2014 140
2015 130
2016 133
2017 136
2018 123
2019 144
2020 147
2021 142
2022 333
2023 185
2024 145
2025 134
2026 71

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,717 results

Results by year

Filters applied: . Clear all
Page 1
Targeting HSP47 for cancer treatment.
Shi R, Yu R, Lian F, Zheng Y, Feng S, Li C, Zheng X. Shi R, et al. Anticancer Drugs. 2024 Aug 1;35(7):623-637. doi: 10.1097/CAD.0000000000001612. Epub 2024 Apr 29. Anticancer Drugs. 2024. PMID: 38718070 Review.
Research progress of CXCR3 inhibitors.
Yuan Z. Yuan Z. Anticancer Drugs. 2024 Jan 1;35(1):36-45. doi: 10.1097/CAD.0000000000001543. Epub 2023 Sep 11. Anticancer Drugs. 2024. PMID: 37694856 Review.
Response to Yilmaz et al.
Cabezas-Camarero S, Iglesias-Moreno MC, Cerezo Druet E, Sotelo MJ, Merino-Menéndez S, Cabrera-Martín MN, Plaza-Hernández JC, Pérez-Segura P. Cabezas-Camarero S, et al. Anticancer Drugs. 2024 Jun 1;35(5):481-482. doi: 10.1097/CAD.0000000000001585. Epub 2024 Apr 3. Anticancer Drugs. 2024. PMID: 38567818 No abstract available.
In regard to Cabezas-Camarero et al.
Yilmaz MT, Yuce Sari S, Yazici G. Yilmaz MT, et al. Anticancer Drugs. 2023 Nov 1;34(10):1202-1204. doi: 10.1097/CAD.0000000000001511. Epub 2023 Oct 11. Anticancer Drugs. 2023. PMID: 37823285 No abstract available.
STK25: a viable therapeutic target for cancer treatments?
Chen KQ, Lei GL, Ke BY, Chen L, Wang ZB, Wang SZ. Chen KQ, et al. Anticancer Drugs. 2023 Oct 1;34(9):995-1001. doi: 10.1097/CAD.0000000000001490. Epub 2023 Dec 23. Anticancer Drugs. 2023. PMID: 36728989 Review.
TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
Chandhasin C, Dang V, Perabo F, Del Rosario J, Chen YK, Filvaroff E, Stafford JA, Clarke M. Chandhasin C, et al. Anticancer Drugs. 2023 Nov 1;34(10):1122-1131. doi: 10.1097/CAD.0000000000001514. Epub 2023 Mar 24. Anticancer Drugs. 2023. PMID: 37067993 Free PMC article.
4,717 results